Evidence map›Paper›PMID 35005124›Full record

ArticleGenes & diseases2022

Corrigendum to "Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma" [Genes Dis 6(4) 2019 407-418].

Junling Tang, Li Zhang, Tiejun Zhou, Zhiwei Sun, Liangsheng Kong, Li Jing, Hongyun Xing, Hongyan Wu, Yongli Liu, Shixia Zhou and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Junling TangLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Li ZhangThe Affiliated Stomatology Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Tiejun ZhouDepartment of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Zhiwei SunLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Liangsheng KongLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Li JingDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Hongyun XingDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Hongyan WuDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Yongli LiuLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Shixia ZhouLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Jingyuan LiLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Mei ChenDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Fang XuDepartment of Hematology, Mianyang Central Hospital, Jingzhong Street, Mianyang, Sichuan 621000, PR China.
Jirui TangDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Tao MaDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Min HuDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Dan LiuDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Jing GuoDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Xiaofeng ZhuDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Yan ChenDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Ting YeLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Jianyu WangLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.
Xiaoming LiDepartment of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China.
H Rosie XingLaboratory of Translational Cancer Stem Cell Research, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.gendis.2018.12.002.].

Identifiers

PMID35005124
PMCPMC8720691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.